A Study To Assess The Safe-Use Conditions For Administration of ZULRESSO® in a Home Setting

Phase 4 Completed 52 enrolled Supernus Pharmaceuticals, Inc.

NaSingle-groupOpen-labelTreatment

Summary

The primary purpose of this study was to evaluate whether the safe-use conditions for administration of brexanolone (ZULRESSO®) can be implemented in a home setting.

Timeline

Start: 2021-10-08
Primary completion: 2022-07-14
Completion: 2022-07-14

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Brexanolone	Unknown	90 ug/kg	Intravenous

A Study To Assess The Safe-Use Conditions For Administration of ZULRESSO® in a Home Setting

Summary

Timeline

Drugs

Indications